This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bioleaders Corporation, Chungbuk National University Industry Academic Cooperation, Kookmin University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 25 
1 out of 1 
1 out of 170 
Years Active: 2016
Title: Innovations of Sang-Mu Shim: Pioneering Adjuvant Composition for Vaccines
Introduction: Sang-Mu Shim is a prominent inventor based in Daejeon, South Korea, known for his groundbreaking work in the field of vaccine adjuvants. With a focus on enhancing vaccine efficacy, Shim has made significant contributions to improving public health through innovative compositions.
Latest Patents: Sang-Mu Shim holds a patent for an "Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles." This invention pertains to an adjuvant composition designed to enhance the effectiveness of vaccines. The adjuvant, which is characterized by minimal toxicity and side effects, utilizes nanoparticles created through ionic bonding between poly-gamma-glutamic acid and chitosan. This composition plays a crucial role in the development of vaccines intended for the prevention and treatment of viral and bacterial infections, as well as cancers, by increasing the production of antibodies in both humans and animals.
Career Highlights: In his professional journey, Shim has been associated with notable organizations, including Bioleaders Corporation and Kookmin University Industry Academy Cooperation Foundation. His work in these institutions showcases his commitment to research and development in innovative biomedical fields.
Collaborations: Throughout his career, Sang-Mu Shim has collaborated with distinguished professionals, including Moon-Hee Sung and Haryoung Poo. These partnerships have likely fostered an environment rich in creativity and innovation, leading to advancements in vaccine technology.
Conclusion: Sang-Mu Shim's contributions to the realm of vaccine adjuvants highlight the importance of innovation in tackling health challenges. His patented adjuvant composition, characterized by safety and efficacy, represents a significant step forward in vaccine development, promising improved outcomes in the fight against infectious diseases and cancers. Shim's ongoing dedication to research signifies a bright future for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile